Bioinformatics startups Benevolent AI and Insilico Medicine using artificial intelligence to discover and accelerate treatments for corona virus

Briefing

Bioinformatics startups Benevolent AI and Insilico Medicine using artificial intelligence to discover and accelerate treatments for corona virus

February 12, 2020

Briefing

  • AI-Based Drug Discovery – London-based Benevolent AI and American startup Insilico Medicine are using artificial intelligence to find potential cure to inhibit spread of 2019 corona virus
  • Potential Drug – Benevolent AI identified one drug (janus kinase inhibitor baricitinib), already being used to treat rheumatoid arthritis, can potentially keep virus from infecting the body
  • How It Works – Drug can strengthen protein called AAK1 in regulating ACE2, protein on cells of kidney, blood vessels and heart that is susceptible to viral infection
  • Clinical Trial – Recommends clinical trial of drug on portion of affected patients as it is safer than other medicines considered
  • Other AI Work – Insilico Medicine identified six molecules using AI that can potentially be exploited to create treatment, publishing their work so other medicinal chemists can study further for possible use
  • Released Genome – Chinese scientists have sequenced genome of the virus which they shared to international community to discover potential vaccine and treaments

Accelerator

Sector

Healthcare/Health Sciences

Function

Research and Development

Organization

BenevolentAI, Insilico Medicine Inc.

Source

Original Publication Date

February 10, 2020

Leave a comment